ArticleMediators of inflammation2026
Pan-Immune-Inflammation Value: Related to Perforation Diameter and Pulmonary Artery Pressure in Ventricular Septal Rupture Patients.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveThis study investigated the relationship between the pan-immune-inflammation value (PIV) and the perforation diameter in patients with ventricular septal rupture (VSR), as well as the changes in pulmonary artery systolic pressure (ΔPASP) after transcatheter closure.
methodsThe clinical data from 133 VSR patients who underwent transcatheter closure were analyzed. Patients were divided into high and low PIV groups based on a median cutoff value of 6. Boruta was used for exploratory variable screening; prespecified covariate sets were used for adjusted models. A generalized additive model (GAM) was used to explore the potential nonlinear relationships. Where a nonlinear association was suggested by the GAM, a piecewise linear regression model was subsequently fitted to precisely quantify the threshold effects and the differential associations of PIV/100 with ΔPASP and perforation diameter on either side of the identified inflection point.
resultsOne hundred thirty-three patients with VSR (mean age 67 years, 50.6% female) were enrolled. Linear regression showed no statistically significant association between PIV/100 and ΔPASP. GAM suggested a possible nonlinear pattern between PIV/100 and ΔPASP (and perforation diameter). In piecewise models, an inverse association was observed above the break point, but this pattern was attenuated after multivariable adjustment and in sensitivity analyses. In discrimination analyses, adding PIV/100 to the baseline model yielded a modest numerical increase in AUC, but the incremental gain was not statistically significant.
conclusionPIV may serve as an adjunct inflammatory marker in VSR patients undergoing transcatheter closure; however, the break point findings are exploratory and the incremental predictive value warrants validation in larger, independent cohorts with better adjudication of infection/systemic inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.